Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meet
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tatva Chintan Pharma Chem has informed the exchanges about an upcoming one-on-one virtual investor meeting scheduled for 24 March 2026 with OysterRock Capital. The disclosure has been made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements. The company has clarified that only publicly available information will be discussed and no unpublished price-sensitive information (UPSI) will be shared. The schedule is subject to change.
This is a routine investor engagement disclosure with no material business update, so it is unlikely to have a meaningful impact on the stock price. Retail investors may note potential institutional interest from OysterRock Capital, but no actionable information has been shared.